Medical Oncology 2, Istituto Oncologico Veneto Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2014
NCT02411344
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now